U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07072572) titled 'Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis' on April 20.
Brief Summary: To guide the administration of intravenous albumin by lung ultrasound in decompensated cirrhosis.
Study Start Date: March 01, 2023
Study Type: INTERVENTIONAL
Condition:
Cirrhosis
Cirrhosis Advanced
Acute Kidney Injury
Ascites
Intervention:
DRUG: Lower albumin dosage
A fixed dose of 35 grams of albumin on they one and day two.
Recruitment Status: COMPLETED
Sponsor: Centro Medico Issemym
Information provided by (Responsible Party): Luis Alejandro Rosales Renteria, Centro Medico Issemym
Published by HT Digital Content Serv...